5-(1H-Pyrazolo[3,4-b]pyridin-3-yl)-1H-pyrrole-3-carboxylicacid
97%
- Product Code: 196804
CAS:
658695-85-3
| Molecular Weight: | 228.207 g./mol | Molecular Formula: | C₁₁H₈N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD20528381 | |
| Melting Point: | Boiling Point: | 648.5±55.0 °C(Predicted) | |
| Density: | 1.65 g/cm3 | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting proteins involved in cancer pathways such as JAK and FLT3. Its structure enables selective binding to ATP sites in kinases, making it valuable in developing drugs for hematological malignancies and inflammatory diseases. Also explored in medicinal chemistry for optimizing lead compounds due to its favorable hydrogen bonding and π-stacking properties.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 250mg | 10-20 days | €119.91 |
+
-
|
| 1g | 10-20 days | €361.30 |
+
-
|
5-(1H-Pyrazolo[3,4-b]pyridin-3-yl)-1H-pyrrole-3-carboxylicacid
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly targeting proteins involved in cancer pathways such as JAK and FLT3. Its structure enables selective binding to ATP sites in kinases, making it valuable in developing drugs for hematological malignancies and inflammatory diseases. Also explored in medicinal chemistry for optimizing lead compounds due to its favorable hydrogen bonding and π-stacking properties.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :